Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study

Detalles Bibliográficos
Autores principales: Martínez, E, Arranz, JA, Podzamczer, D, Lonca, M, Sanz, J, Barragán, P, Knobel, H, Ribera, E, Gutierrez, F, Valero, S, Clotet, B, Dalmau, D, Segura, F, Arribas, JR, Barrufet, P, Santos, I, Payeras, A, de Lazzari, E, Pich, J, Gatell, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113046/
http://dx.doi.org/10.1186/1758-2652-13-S4-P43
_version_ 1782205875756204032
author Martínez, E
Arranz, JA
Podzamczer, D
Lonca, M
Sanz, J
Barragán, P
Knobel, H
Ribera, E
Gutierrez, F
Valero, S
Clotet, B
Dalmau, D
Segura, F
Arribas, JR
Barrufet, P
Santos, I
Payeras, A
de Lazzari, E
Pich, J
Gatell, J
author_facet Martínez, E
Arranz, JA
Podzamczer, D
Lonca, M
Sanz, J
Barragán, P
Knobel, H
Ribera, E
Gutierrez, F
Valero, S
Clotet, B
Dalmau, D
Segura, F
Arribas, JR
Barrufet, P
Santos, I
Payeras, A
de Lazzari, E
Pich, J
Gatell, J
author_sort Martínez, E
collection PubMed
description
format Online
Article
Text
id pubmed-3113046
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31130462011-06-13 Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study Martínez, E Arranz, JA Podzamczer, D Lonca, M Sanz, J Barragán, P Knobel, H Ribera, E Gutierrez, F Valero, S Clotet, B Dalmau, D Segura, F Arribas, JR Barrufet, P Santos, I Payeras, A de Lazzari, E Pich, J Gatell, J J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113046/ http://dx.doi.org/10.1186/1758-2652-13-S4-P43 Text en Copyright ©2010 Gatell et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Martínez, E
Arranz, JA
Podzamczer, D
Lonca, M
Sanz, J
Barragán, P
Knobel, H
Ribera, E
Gutierrez, F
Valero, S
Clotet, B
Dalmau, D
Segura, F
Arribas, JR
Barrufet, P
Santos, I
Payeras, A
de Lazzari, E
Pich, J
Gatell, J
Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study
title Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study
title_full Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study
title_fullStr Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study
title_full_unstemmed Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study
title_short Long-term outcomes of switching to fixed-dose abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC): 3-year results of the BICOMBO study
title_sort long-term outcomes of switching to fixed-dose abacavir/lamivudine (abc/3tc) or tenofovir/emtricitabine (tdf/ftc): 3-year results of the bicombo study
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113046/
http://dx.doi.org/10.1186/1758-2652-13-S4-P43
work_keys_str_mv AT martineze longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT arranzja longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT podzamczerd longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT loncam longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT sanzj longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT barraganp longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT knobelh longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT riberae longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT gutierrezf longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT valeros longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT clotetb longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT dalmaud longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT seguraf longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT arribasjr longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT barrufetp longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT santosi longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT payerasa longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT delazzarie longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT pichj longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy
AT gatellj longtermoutcomesofswitchingtofixeddoseabacavirlamivudineabc3tcortenofoviremtricitabinetdfftc3yearresultsofthebicombostudy

Ejemplares similares